Tags: Drug.

Tasimelteon (trade name Hetlioz previously known as BMS-214778) is a drug approved solely for the treatment of non-24-hour sleep–wake disorder in totally blind people. It was under development for the treatment of insomnia and other sleep disorders. It is a selective agonist for the melatonin receptors MT1 and MT2 in the suprachiasmatic nucleus of the brain similar to older drugs such as ramelteon.

Tasimelteon_2.svg
ATC prefix
none
CAS number
609799-22-6
FDA UNII code
SHS4PU80D9
IUPAC name
(1R 2R)-N-[2-(23-dihydrobenzofuran-4-yl)cyclopropylmethyl]propanamide
PubChem
10220503

Loading...

This page contains content from the copyrighted Wikipedia article "Tasimelteon"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.